Atherogenic lipid profiles and its management in patients with rheumatoid arthritis

References

• American College of Rheumatology Subcommittee on Rheumatoid ArthritisGuidelines for the management of rheumatoid arthritis: 2002 updateArthritis Rheum2002463284611840435
   PubMed Web of Science ®Google Scholar
• AnsellBJNavabMWatsonKEAnti-inflammatory properties of HDLRev Endocr Metab Disord20045351815486468
   PubMed Web of Science ®Google Scholar
• AsanumaYKawaiSAoshimaHSerum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritisArthritis Rheum199942443710088766
   PubMed Web of Science ®Google Scholar
• BanksMFlintJBaconPARheumatoid arthritis is an independent risk factor for ischaemic heart disease [abstract]Arthritis Rheum200043Suppl9S385
   Google Scholar
• BoersMVerhoevenACMarkusseHMRandomised comparison of combined step-down prednisolon, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritisLancet1997350309189251634
   PubMed Web of Science ®Google Scholar
• BoersMRheumatoid arthritis: Treatment of early diseaseRheum Dis Clin North Am2001274051411396100
   PubMed Web of Science ®Google Scholar
• BoersMNurmohamedMTDoelmanCJInfluence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritisAnn Rheum Dis200362842512922956
   PubMed Web of Science ®Google Scholar
• BoersMDijkmansBGabrielSMaking an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidityArthritis Rheum2004501734915188348
   PubMed Web of Science ®Google Scholar
• CantinBGagnonFMoorjaniSIs lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular StudyJ Am Coll Cardiol199831519259502629
   PubMed Web of Science ®Google Scholar
• CauzaECauzaKHanusch-EnsererUIntravenous anti-TNF-alpha therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritisWien Klin Wochenschr2002301004712635469
   PubMedGoogle Scholar
• DahlqvistSREngstrandSBerglinEConversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapyScand J Rheumatol2006351071116641043
   PubMed Web of Science ®Google Scholar
• DesseinPHJoffeBIVellerMGTraditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in RAJ Rheumatol2005324354215742434
   PubMed Web of Science ®Google Scholar
• FriesJFCurrent treatment paradigms in rheumatoid arthritisRheumatology200039(suppl)130511001377
   PubMedGoogle Scholar
• GeorgiadisANPapavasiliouECLouridaESAtherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment – a prospective, controlled studyArthritis Res Ther20068R82 Epub 2006 Apr 2816646989
   PubMed Web of Science ®Google Scholar
• GoodsonNJSolomonDHThe cardiovascular manifestations of rheumatic diseasesCurr Opin Rheumatol2006181354016462518
   PubMed Web of Science ®Google Scholar
• GordonDJKnokeJProbstfieldJLHigh-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: The Lipid Research Clinics Coronary Primary Prevention TrialCirculation1986741217253536151
   PubMed Web of Science ®Google Scholar
• HeldenbergDCaspiDLevtovOSerum lipids and lipoprotein concentrations in women with rheumatoid arthritisClin Rheumatol19832387916678199
   PubMed Web of Science ®Google Scholar
• Hurt-CamejoEParedesSMasanaLElevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profileArthritis Rheum2001442761711762936
   PubMed Web of Science ®Google Scholar
• JacobssonLTTuressonCGülfeALow incidence of first cardiovascular event in rheumatoid arthritis patients treated with TNF-blockersJ Rheumatol20053212131815996054
   PubMed Web of Science ®Google Scholar
• JacobssonLTTuressonCNilssonJATreatment with TNF-blockers and mortality risk in patients with rheumatoid arthritisAnn Rheum Dis20061211 Epub ahead of print
   Google Scholar
• KavanaughADyslipoproteinaemia in a subset of patients with rheumatoid arthritisAnn Rheum Dis19945355127944646
   PubMedGoogle Scholar
• KiortsisDNMavridisAKFilippatosTDEffects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitisJ Rheumatol200633921316541480
   PubMed Web of Science ®Google Scholar
• KirwanJRSystemic low-dose glucocorticoid in rheumatoid arthritisRheum Dis Clin North Am20012738940311396099
   PubMed Web of Science ®Google Scholar
• KotlerDPCachexiaAnn Intern Med20001336223411033592
   PubMed Web of Science ®Google Scholar
• LakatosJHarsagyiASerum total, HDL, LDL cholesterol and triglyceride levels in patients with rheumatoid arthritisClin Biochem1988219363390902
   PubMed Web of Science ®Google Scholar
• LeeYHChoiSJJiJDLipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritisClin Rheumatol2000193242510941819
   PubMed Web of Science ®Google Scholar
• LemsWFDijkmansBACFiresteinGSPanayiGSWollheimFARheumatoid arthritis: clinical aspects and its variantsRheumatoid arthritis: new frontiers in pathogenesis and treatment2000New YorkOxford University Press21325
   Google Scholar
• LorberMAviramMLinnSHypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritisBr J Rheumatol19852425053860273
   PubMedGoogle Scholar
• Maradit-KremersHCrowsonCSNicolaPJIncreased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort studyArthritis Rheum2005524021115693010
   PubMed Web of Science ®Google Scholar
• Maradit-KremersHNicolaPJCrowsonCSCardiovascular death in rheumatoid arthritis: a population-based studyArthritis Rheum2005527223215751097
   PubMed Web of Science ®Google Scholar
• McCareyDWMcInnesIBMadhokRTrial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trialLancet200436320152115207950
   PubMed Web of Science ®Google Scholar
• McMahonMGrossmanJFitzGeraldJProinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritisArthritis Rheum2006542541916868975
   PubMed Web of Science ®Google Scholar
• MenottiALantiMCoronary risk factors predicting early and late coronary deathsHeart200389192412482784
   PubMed Web of Science ®Google Scholar
• MenottiAKromhoutDBlackburnHForty-year mortality from cardiovascular diseases and all causes of death in the US Railroad cohort of the Seven Countries StudyEur J Epidemiol2004194172415233313
   PubMed Web of Science ®Google Scholar
• MunroRMorrisonEMcDonaldAGEffect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritisAnn Rheum Dis19975637479227167
   PubMed Web of Science ®Google Scholar
• NavabMHamaSYHoughGPA cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipidsJ Lipid Res20014213081711483633
   PubMed Web of Science ®Google Scholar
• ParkYBLeeSKLeeWKLipid profiles in untreated patients with rheumatoid arthritisJ Rheumatol1999261701410451065
   PubMed Web of Science ®Google Scholar
• ParkYBChoiHKKimMYEffects of antirheumatic therapy on serum levels in patients with rheumatoid arthritis: a prospective studyAm J Med20021131889312208376
   PubMed Web of Science ®Google Scholar
• PetersMJVisMvan HalmVPChanges in lipid profile during infliximab treatment and corticosteroid therapy in rheumatoid arthritisAnn Rheum Dis2007221 Epub ahead of print
   PubMedGoogle Scholar
• PincusTCallahanLTaking mortality in rheumatoid arthritis seriously – predictive markers, socioeconomic status and comorbidityJ Rheumatol19861384153820193
   PubMed Web of Science ®Google Scholar
• PopaCNeteaMGRadstakeTInfluence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritisAnn Rheum Dis200564303515231512
   PubMed Web of Science ®Google Scholar
• RaderDJHoegJMBrewerHBJrQuantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery diseaseAnn Intern Med19941201012258185133
   PubMed Web of Science ®Google Scholar
• Rantapaa-DahlqvistSWallberg-JonssonSDahlenGLipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritisAnn Rheum Dis19995036681829348
   PubMedGoogle Scholar
• RauRFiresteinGSPanayiGSWollheimFAMethotrexateRheumatoid arthritis: new frontiers in pathogenesis and treatment2000Oxford (NY)Oxford University Press33750
   Google Scholar
• RedelmeierDATanSHBoothGLThe treatment of unrelated disorders in patients with chronic medical diseasesN Engl J Med19983381516209593791
   PubMed Web of Science ®Google Scholar
• RubinsHBRobinsSJCollinsDGemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study GroupN Engl J Med19993414101810438259
   PubMed Web of Science ®Google Scholar
• SattarNMcCareyDWCappelHExplaining how ‘high-grade’ systemic inflammation accelerates vascular risk in rheumatoid arthritisCirculation200310829576314676136
   PubMed Web of Science ®Google Scholar
• SerioloBPaolinoSSulliAEffects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritisAnn N Y Acad Sci200610694141916855168
   PubMed Web of Science ®Google Scholar
• SharrettARBallantyneCMCoadySACoronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) StudyCirculation200110411081311535564
   PubMed Web of Science ®Google Scholar
• SolomonDHKarlsonEWRimmEBCardiovascular morbidity and mortality in women diagnosed witch rheumatoid arthritisCirculation20031071303712628952
   PubMed Web of Science ®Google Scholar
• SpanakisESidiropoulosPPapadakisJModest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximabJ Rheumatol2006332440617014005
   PubMed Web of Science ®Google Scholar
• SprecherDLWatkinsTRBeharSImportance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart diseaseAm J Cardiol2003915758012615263
   PubMed Web of Science ®Google Scholar
• StampferMJSacksFMSalviniSA prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarctionN Engl J Med1991325373812062328
   PubMed Web of Science ®Google Scholar
• SvensonKLGLithellHHällgrenSerum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I Relativity to inflammatory activityArch Intern Med1987a1471912163675091
   PubMedGoogle Scholar
• SvensonKLGLithellHHällgrenSerum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. Effects of anti-inflammatory and disease-modifying drug treatmentArch Intern Med1987b1471917203675092
   PubMedGoogle Scholar
• The Framingham Study: Coronary risk handbook using HDL-cholesterol for persons over 501978BethesdaNational Heart, Lung and Blood Institute
   Google Scholar
• Van DoornumSMcGollGWicksIPAccelerated atherosclerosis: an extraarticular feature of rheumatoid arthritisArthritis Rheum2002468627311953961
   PubMed Web of Science ®Google Scholar
• Van HalmVPNielenMMNurmohamedMTLipids and inflammation – serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritisAnn Rheum Dis200667 Epub ahead of print
   Web of Science ®Google Scholar
• Van HalmVPNurmohamedMTTwiskJWDisease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control studyArthritis Res Ther20069208R151 Epub ahead of print
   PubMed Web of Science ®Google Scholar
• VisMNurmohamedMTWolbinkGShort term effects of infliximab on the lipid Profile in patients with rheumatoid arthritisJ Rheumatol200532252515693084
   PubMed Web of Science ®Google Scholar
• Wallberg-JonssonSOhmanMLDahlqvistSRCardiovascularmorbidity and mortality in patients with seropositive rheumatoid arthritis in northern SwedenJ Rheumatol199724445519058647
   PubMed Web of Science ®Google Scholar
• WalldiusGJungnerIHolmeIHigh apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective studyLancet200135820263311755609
   PubMed Web of Science ®Google Scholar
• WalldiusGJungnerIThe apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy – a review of the evidenceJ Intern Med200625949351916629855
   PubMed Web of Science ®Google Scholar
• WalsmithJAbadLKehayiasJRoubenoffRTumor necrosis factor-α production is associated with less body cell mass in women with rheumatoid arthritisJ Rheumatol20043123914705214
   PubMed Web of Science ®Google Scholar
• WhiteDFayezSDoubeAAtherogenic lipid profiles in rheumatoid arthritisN Z Med2006119U2125
   PubMedGoogle Scholar